Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Spironolactone in Alcohol Use Disorder (SAUD) [Phase 1]

View source ↗

Summary

This document notes an ongoing Phase 1 clinical trial evaluating spironolactone for alcohol use disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Alcohol Use Disorder | Phase 1 | Status: RECRUITING